LabCompass

Paul Monk

Medicine · The Ohio State University

Established · publishing since 1995

Publications

104

Citations

1,384

Est. group size

~18

Recurring co-author estimate

Active years

32

Publishing since 1995

Research summary
AI-generated

Paul Monk's research centers on clinical trials for genitourinary cancers, especially metastatic castration-resistant prostate cancer, testing new drug combinations such as immune activators, hormone-pathway inhibitors, and immunotherapies. His work also extends to bladder and kidney cancer treatment studies, largely through multi-site phase I-III clinical trials. This work is aimed at evaluating new and combination therapies to improve outcomes for patients with advanced prostate and other urologic cancers.

Metastatic castration-resistant prostate cancer treatmentClinical trials for genitourinary cancersImmunotherapy and immune-activating combination drugsAndrogen and hormone receptor-targeted therapyBladder and renal cell carcinoma treatment research

Publication output has fluctuated over the past decade but shows an overall increase, with output rising notably in 2024 and 2025 compared to earlier years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 7.6/year recently
2017: 4 publications172018: 10 publications182019: 8 publications192020: 11 publications202021: 12 publications212022: 4 publications222023: 6 publications232024: 16 publications16242025: 11 publications252026: 1 publication26
Recent publications
Publishes in
  • Journal of Clinical Oncology×47
  • Annals of Oncology×6
  • Journal of the National Comprehensive Cancer Network×2
  • Cancer Medicine×2
  • Cancer Research×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile